Literature DB >> 25356950

Poor symptom control is associated with reduced CT scan segmental airway lumen area in smokers with asthma.

Neil C Thomson1, Rekha Chaudhuri2, Mark Spears2, Claudia-Martina Messow3, William MacNee4, Martin Connell4, John T Murchison4, Michael Sproule5, Charles McSharry2.   

Abstract

BACKGROUND: Cigarette smoking is associated with worse symptoms in asthma and abnormal segmental airways in healthy subjects. We tested the hypothesis that current symptom control in smokers with asthma is associated with altered segmental airway dimensions measured by CT scan.
METHODS: In 93 subjects with mild, moderate, and severe asthma (smokers and never smokers), we recorded Asthma Control Questionnaire-6 (ACQ-6) score, spirometry (FEV1; forced expiratory flow rate, midexpiratory phase [FEF(25%-75%)]), residual volume (RV), total lung capacity (TLC), and CT scan measures of the right bronchial (RB) and left bronchial (LB) segmental airway dimensions (wall thickness, mm; lumen area, mm²) in the RB3/LB3, RB6/LB6, and RB10/LB10 (smaller) airways.
RESULTS: The CT scan segmental airway (RB10 and LB10) lumen area was reduced in smokers with asthma compared with never smokers with asthma; RB10, 16.6 mm² (interquartile range, 12.4-19.2 mm²) vs 19.6 mm² (14.7-24.2 mm²) (P = .01); LB10, 14.8 mm² (12.1-19.0 mm²) vs 19.9 mm² (14.5-25.0 mm²) (P = .003), particularly in severe disease, with no differences in wall thickness or in larger airway (RB3 and LB3) dimensions. In smokers with asthma, a reduced lumen area in fifth-generation airways (RB10 or LB10) was associated with poor symptom control (higher ACQ-6 score) (-0.463 [-0.666 to -0.196], P = .001, and -0.401 [-0.619 to -0.126], P = .007, respectively) and reduced postbronchodilator FEF(25%-75%) (0.521 [0.292-0.694], P < .001, and [0.471 [0.236-0.654], P = .001, respectively) and higher RV/TLC %.
CONCLUSIONS: The CT scan segmental airway lumen area is reduced in smokers with asthma compared with never smokers with asthma, particularly in severe disease, and is associated with worse current symptom control and small airway dysfunction.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25356950     DOI: 10.1378/chest.14-1119

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Airway tree reconstruction in expiration chest CT scans facilitated by information transfer from corresponding inspiration scans.

Authors:  Christian Bauer; Michael Eberlein; Reinhard R Beichel
Journal:  Med Phys       Date:  2016-03       Impact factor: 4.071

Review 2.  The role of imaging in the assessment of severe asthma.

Authors:  Samuel Y Ash; Alejandro A Diaz
Journal:  Curr Opin Pulm Med       Date:  2017-01       Impact factor: 3.155

3.  Role of FEF25-75 in managing children with newly-diagnosed asthma in clinical practice.

Authors:  Giorgio Ciprandi; Maria Angela Tosca; Irene Schiavetti; Roberta Olcese; Michele Miraglia Del Giudice
Journal:  Acta Biomed       Date:  2022-08-31

4.  Bronchial wall parameters on CT in healthy never-smoking, smoking, COPD, and asthma populations: a systematic review and meta-analysis.

Authors:  Ivan Dudurych; Susan Muiser; Niall McVeigh; Huib A M Kerstjens; Maarten van den Berge; Marleen de Bruijne; Rozemarijn Vliegenthart
Journal:  Eur Radiol       Date:  2022-02-22       Impact factor: 7.034

5.  Elevated expression of placental growth factor is associated with airway-wall vascular remodelling and thickening in smokers with asthma.

Authors:  Dong Wu; Tianwen Lai; Yalian Yuan; Min Chen; Jun Xia; Wen Li; Guihai Pan; Binfan Yuan; Quanchao Lv; Yanyu Li; Dongmin Li; Bin Wu
Journal:  Sci Rep       Date:  2017-02-21       Impact factor: 4.379

Review 6.  The management of asthmatic smokers.

Authors:  José Miguel Chatkin; Cynthia Rocha Dullius
Journal:  Asthma Res Pract       Date:  2016-06-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.